Plain-English translation of NCT05106270 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atrial Fibrillation research guide →This trial is studying a combined procedure for people with atrial fibrillation—a condition where the heart beats irregularly. The procedure combines two treatments done at the same time: catheter ablation (which uses heat or cold to fix the irregular heartbeat) and left atrial appendage closure (a device placed in the heart to prevent clots and stroke). Researchers want to measure how the pressures in your heart chambers change during and after the procedure, and whether these changes affect your long-term health outcomes.
Many people with atrial fibrillation are at high risk for stroke but cannot take blood thinning medications due to side effects or other medical reasons. This trial wants to understand whether doing both treatments together—fixing the heartbeat and closing off the area where clots can form—improves outcomes, and how measuring heart pressure during the procedure might help predict who will do well.
You likely qualify if…
You likely don't qualify if…
You will undergo a combined procedure where doctors perform catheter ablation first (using heat or cold to isolate the pulmonary veins in your heart), then immediately place a closure device in your left atrial appendage (a pouch in your heart where clots can form). During the procedure, the doctors will measure the pressures in your heart chambers at several specific time points. After the procedure is complete, you will be followed up to track whether you have any heart-related hospitalizations or other health events, which helps doctors understand how the treatment affects your long-term recovery.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
China